Virios Therapeutics, Inc. Disclosure

Virios Therapeutics, Inc. (NASDAQ: VIRI) is a client of PCG Advisory, Inc. Virios Therapeutics, Inc. has an agreement in place to pay PCG a monthly cash fee of $15,000 for PCG investor awareness and investor relations advisory services.

Investor awareness and investor relations services and programs are designed to help small-cap companies communicate their investment characteristics. PCG investor awareness and advisory services include multimedia marketing and other awareness services.